Filtered Listing Testing

BrightFocus Foundation announces a new national public service campaign to increase awareness and understanding of Alzheimer’s disease.

The winter 2019 edition of the National Glaucoma Research Report provides answers to the top five questions asked about glaucoma, describes a new method to inhibit inflammation and prevent glaucoma, lists several apps for people with low vision, outlines a clinical research study underway to save sight from glaucoma, and more.

Learn about a new approach for memory improvement in Alzheimer's disease, a study exploring selective memory in the Alzheimer’s disease brain, research disaster preparedness for Alzheimer’s caregivers, how to reduce the risk of vascular dementia with a brain-healthy lifestyle, and more in the 2019 winter edition of Alzheimer's Disease Research Review..

A new blood-based Alzheimer’s screening test, created with a grant from BrightFocus, received a “Breakthrough Device” designation by the FDA. This speeds up its timeline for possible approval and public use.

Rudolph E. Tanzi, PhD and Se Hoon Choi, PhD have managed to accomplish what no one has done before. They grew human brain cells in a petri dish using a gel culture, and then infiltrated them with genes that encode for amyloid precursor protein and presenilin1, both of which were earlier discoveries in Tanzi’s lab and are associated with the most robustly inheritable, early-onset familial forms of Alzheimer’s disease.

All mouse models used to represent Alzheimer’s disease are imperfect, and can only approximate how the disease develops in humans. However, a BrightFocus-funded research project is being hailed as a game-changer that could make results highly relevant to human disease.

Why the prevention or treatment of Alzheimer's disease can only happen with the generosity and commitment of volunteers enrolling in clinical trials.